1
|
Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.
|
Lancet
|
2004
|
2.91
|
2
|
Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.
|
Arch Neurol
|
2012
|
2.61
|
3
|
Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.
|
Proc Natl Acad Sci U S A
|
2010
|
2.32
|
4
|
Cognitive reserve hypothesis: Pittsburgh Compound B and fluorodeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease.
|
Ann Neurol
|
2008
|
2.24
|
5
|
Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.
|
Arch Neurol
|
2008
|
2.19
|
6
|
The use of PET in Alzheimer disease.
|
Nat Rev Neurol
|
2010
|
2.13
|
7
|
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2008
|
2.04
|
8
|
Binge drinking in midlife and dementia risk.
|
Epidemiology
|
2005
|
1.61
|
9
|
Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457.
|
J Neurosci
|
2005
|
1.58
|
10
|
The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects.
|
Eur J Nucl Med Mol Imaging
|
2008
|
1.55
|
11
|
Effects of intravenous glucose on dopaminergic function in the human brain in vivo.
|
Synapse
|
2007
|
1.46
|
12
|
Brain white matter expansion in human obesity and the recovering effect of dieting.
|
J Clin Endocrinol Metab
|
2007
|
1.46
|
13
|
Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.
|
Arch Neurol
|
2008
|
1.31
|
14
|
Characteristics of two telephone screens for cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2002
|
1.31
|
15
|
Effects of working-memory training on striatal dopamine release.
|
Science
|
2011
|
1.30
|
16
|
Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
|
Pain
|
2003
|
1.29
|
17
|
Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.
|
Parkinsonism Relat Disord
|
2008
|
1.15
|
18
|
Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.
|
Eur J Nucl Med Mol Imaging
|
2014
|
1.11
|
19
|
Altered dopamine D2 receptor binding in atypical facial pain.
|
Pain
|
2003
|
1.10
|
20
|
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity.
|
Synapse
|
2009
|
1.10
|
21
|
Mesolimbic dopamine release is linked to symptom severity in pathological gambling.
|
Neuroimage
|
2012
|
1.07
|
22
|
Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.
|
Synapse
|
2015
|
1.05
|
23
|
Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
|
Mov Disord
|
2006
|
1.05
|
24
|
Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease.
|
Neurosci Biobehav Rev
|
2002
|
1.04
|
25
|
Mobile phone affects cerebral blood flow in humans.
|
J Cereb Blood Flow Metab
|
2006
|
1.03
|
26
|
Insular dopamine D2 receptors and novelty seeking personality in Parkinson's disease.
|
Mov Disord
|
2004
|
1.03
|
27
|
Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.
|
Neurobiol Aging
|
2005
|
1.02
|
28
|
Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
|
J Clin Psychopharmacol
|
2002
|
1.01
|
29
|
Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease.
|
J Nucl Med
|
2013
|
1.00
|
30
|
Posterior cortical atrophy: a rare form of dementia with in vivo evidence of amyloid-beta accumulation.
|
J Alzheimers Dis
|
2008
|
0.98
|
31
|
Biodistribution and radiation dosimetry of the amyloid imaging agent 11C-PIB in humans.
|
J Nucl Med
|
2007
|
0.97
|
32
|
Effects of a 902 MHz mobile phone on cerebral blood flow in humans: a PET study.
|
Neuroreport
|
2003
|
0.97
|
33
|
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents.
|
Neurobiol Aging
|
2012
|
0.96
|
34
|
Age-related loss of extrastriatal dopamine D(2) -like receptors in women.
|
J Neurochem
|
2002
|
0.96
|
35
|
Midlife sleep characteristics associated with late life cognitive function.
|
Sleep
|
2013
|
0.96
|
36
|
Dopaminergic effects of caffeine in the human striatum and thalamus.
|
Neuroreport
|
2004
|
0.94
|
37
|
Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
|
J Nucl Med
|
2009
|
0.94
|
38
|
Positron emission tomography examination of cerebral blood flow and glucose metabolism in young CADASIL patients.
|
Stroke
|
2004
|
0.93
|
39
|
Visual assessment of [(11)C]PIB PET in patients with cognitive impairment.
|
Eur J Nucl Med Mol Imaging
|
2010
|
0.93
|
40
|
Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
|
Mov Disord
|
2012
|
0.92
|
41
|
Human biodistribution and radiation dosimetry of 11C-(R)-PK11195, the prototypic PET ligand to image inflammation.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.92
|
42
|
Coffee drinking in middle age is not associated with cognitive performance in old age.
|
Am J Clin Nutr
|
2009
|
0.91
|
43
|
Pharmacokinetics of [¹⁸F]flutemetamol in wild-type rodents and its binding to beta amyloid deposits in a mouse model of Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2012
|
0.90
|
44
|
Cognitive slowing in Parkinson's disease is related to frontostriatal dopaminergic dysfunction.
|
J Neurol Sci
|
2013
|
0.89
|
45
|
Expectation of caffeine induces dopaminergic responses in humans.
|
Eur J Neurosci
|
2004
|
0.89
|
46
|
Midlife alcohol consumption and later risk of cognitive impairment: a twin follow-up study.
|
J Alzheimers Dis
|
2010
|
0.89
|
47
|
Naming of newly learned objects: a PET activation study.
|
Brain Res Cogn Brain Res
|
2005
|
0.87
|
48
|
Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.87
|
49
|
Whole-body distribution and metabolism of [N-methyl-11C](R)-1-(2-chlorophenyl)-N-(1-methylpropyl)-3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.87
|
50
|
No association between the brain-derived neurotrophic factor 196 G>A or 270 C>T polymorphisms and Alzheimer's or Parkinson's disease.
|
Folia Neuropathol
|
2006
|
0.87
|
51
|
A follow-up study on 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease shows nonlinear progression in the putamen.
|
Mov Disord
|
2009
|
0.86
|
52
|
Diagnostic effectiveness of quantitative [¹⁸F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subjects with idiopathic normal pressure hydrocephalus.
|
Acta Neuropathol Commun
|
2014
|
0.86
|
53
|
Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study.
|
J Cereb Blood Flow Metab
|
2013
|
0.86
|
54
|
Reproducibility of striatal and thalamic dopamine D2 receptor binding using [11C]raclopride with high-resolution positron emission tomography.
|
J Cereb Blood Flow Metab
|
2010
|
0.86
|
55
|
Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
|
Eur Neurol
|
2010
|
0.86
|
56
|
COMT Val158Met genotype does not alter cortical or striatal dopamine D2 receptor availability in vivo.
|
Mol Imaging Biol
|
2009
|
0.85
|
57
|
Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
|
Synapse
|
2003
|
0.85
|
58
|
Midlife cardiovascular risk factors and late cognitive impairment.
|
Eur J Epidemiol
|
2013
|
0.84
|
59
|
Acute hormonal changes following intravenous glucose challenge in lean and obese human subjects.
|
Scand J Clin Lab Invest
|
2010
|
0.84
|
60
|
Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns.
|
Neurosci Lett
|
2004
|
0.84
|
61
|
[(11)C]PIB-, [(18)F]FDG-PET and MRI imaging in patients with Parkinson's disease with and without dementia.
|
Parkinsonism Relat Disord
|
2010
|
0.84
|
62
|
A rare mitochondrial DNA haplotype observed in Koreans.
|
Hum Biol
|
2002
|
0.83
|
63
|
Visual object recognition deficits in early Parkinson's disease.
|
Parkinsonism Relat Disord
|
2004
|
0.83
|
64
|
Brain oscillatory responses to an auditory-verbal working memory task in mild cognitive impairment and Alzheimer's disease.
|
Int J Psychophysiol
|
2005
|
0.83
|
65
|
Different cerebral cortical areas influence the effect of subthalamic nucleus stimulation on parkinsonian motor deficits and freezing of gait.
|
Mov Disord
|
2007
|
0.83
|
66
|
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.82
|
67
|
Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.
|
Brain Res
|
2002
|
0.82
|
68
|
Carbon monoxide poisoning-induced nigrostriatal dopaminergic dysfunction detected using positron emission tomography (PET).
|
Neurotoxicology
|
2010
|
0.81
|
69
|
Cerebral oxygen and glucose metabolism in patients with mitochondrial m.3243A>G mutation.
|
Brain
|
2009
|
0.81
|
70
|
Brain function during multi-trial learning in mild cognitive impairment: a PET activation study.
|
Brain Res
|
2007
|
0.81
|
71
|
Effects of intravenous placebo with glucose expectation on human basal ganglia dopaminergic function.
|
Synapse
|
2008
|
0.81
|
72
|
Personality traits and striatal 6-[18F]fluoro-L-dopa uptake in healthy elderly subjects.
|
Neurosci Lett
|
2002
|
0.80
|
73
|
Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
|
Neuroimage
|
2013
|
0.80
|
74
|
Radiopharmaceuticals for positron emission tomography investigations of Alzheimer's disease.
|
Eur J Nucl Med Mol Imaging
|
2009
|
0.80
|
75
|
1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
|
J Nucl Med
|
2008
|
0.80
|
76
|
Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
|
Mult Scler
|
2011
|
0.79
|
77
|
GSM mobile phone radiation suppresses brain glucose metabolism.
|
J Cereb Blood Flow Metab
|
2011
|
0.79
|
78
|
[11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: a Bayesian method and voxel-based analysis.
|
J Alzheimers Dis
|
2012
|
0.79
|
79
|
Absence of association between an intercellular adhesion molecule 1 gene E469K polymorphism and Alzheimer's disease in Finnish patients.
|
Neurosci Lett
|
2003
|
0.78
|
80
|
Seasonality of striatal dopamine synthesis capacity in Parkinson's disease.
|
Neurosci Lett
|
2012
|
0.78
|
81
|
Cost-utility model of rasagiline in the treatment of advanced Parkinson's disease in Finland.
|
Ann Pharmacother
|
2006
|
0.77
|
82
|
¹¹C-ORM-13070, a novel PET ligand for brain α₂C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men.
|
Eur J Nucl Med Mol Imaging
|
2014
|
0.77
|
83
|
No effects of short-term GSM mobile phone radiation on cerebral blood flow measured using positron emission tomography.
|
Bioelectromagnetics
|
2011
|
0.77
|
84
|
Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2007
|
0.77
|
85
|
Different brain activation patterns during production of animals versus artefacts: a PET activation study on category-specific processing.
|
Brain Res Cogn Brain Res
|
2002
|
0.77
|
86
|
Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease.
|
Dement Geriatr Cogn Disord
|
2003
|
0.77
|
87
|
Naming multiple objects: neural correlates as measured by positron emission tomography.
|
Appl Neuropsychol
|
2003
|
0.77
|
88
|
Central executive function in mild cognitive impairment: a PET activation study.
|
Scand J Psychol
|
2008
|
0.77
|
89
|
Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson's disease.
|
J Parkinsons Dis
|
2013
|
0.77
|
90
|
Neural correlates of naming newly learned objects in MCI.
|
Neuropsychologia
|
2007
|
0.76
|
91
|
Learning and forgetting new names and objects in MCI and AD.
|
Neuropsychologia
|
2009
|
0.76
|
92
|
Brain ¹⁸F-FDG and ¹¹C-PiB PET findings in two siblings with FTD/ALS associated with the C9ORF72 repeat expansion.
|
Neurocase
|
2012
|
0.76
|
93
|
Shorter adult stature increases the impact of risk factors for cognitive impairment: a comparison of two Nordic twin cohorts.
|
Twin Res Hum Genet
|
2011
|
0.76
|
94
|
Brain volumetric correlates of memory in early Parkinson's disease.
|
J Parkinsons Dis
|
2013
|
0.76
|
95
|
A 90-year-old monozygotic female twin pair discordant for Alzheimer's disease.
|
Neurobiol Aging
|
2003
|
0.76
|
96
|
Neuropsychological functions in variant Alzheimer's disease with spastic paraparesis.
|
J Neurol Sci
|
2004
|
0.75
|
97
|
Boxing and Parkinson disease: a link or a myth? An 18F-FDOPA PET/CT study in retired Thai traditional boxers.
|
Parkinsonism Relat Disord
|
2012
|
0.75
|
98
|
Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson's disease.
|
J Neural Transm (Vienna)
|
2013
|
0.75
|
99
|
Brain Cholinergic Function and Response to Rivastigmine in Patients With Chronic Sequels of Traumatic Brain Injury: A PET Study.
|
J Head Trauma Rehabil
|
2017
|
0.75
|
100
|
Cognitive decline and amyloid accumulation in patients with mild cognitive impairment.
|
Dement Geriatr Cogn Disord
|
2012
|
0.75
|
101
|
The relationship between recognition memory for emotion-laden words and white matter microstructure in normal older individuals.
|
Neuroreport
|
2016
|
0.75
|
102
|
Comparison of manual and automatic techniques for substriatal segmentation in 11C-raclopride high-resolution PET studies.
|
Nucl Med Commun
|
2016
|
0.75
|
103
|
19F/18F exchange synthesis for a novel [18F]S1P3-radiopharmaceutical.
|
J Labelled Comp Radiopharm
|
2013
|
0.75
|